Streamlined workflow to screen and diagnose trinucleotide repeat disorders.
Seasoned executives with management experience and technical expertise.
Rapid diagnostic kits for Fragile X Syndrome and Myotonic Dystrophy Type 1.
From testing for Fragile X Syndrome to Myotonic Dystrophy Type 1.
TNR Diagnostics has developed in-vitro diagnostic kits for major trinucleotide repeat disorders such as Fragile X Syndrome and Myotonic Dystrophy Type 1 to overcome the current challenges in screening and analysis of these inherited disorders. TNR Diagnostics introduces a simple and streamlined workflow to ease the workload and increase productivity for the end-users.